- Investing Ideas
- /
- Global Pharmaceuticals & Biotech The Future Is Online
Global Pharmaceuticals & Biotech The Future Is Online
UPDATED Jun 14, 2023
A list of some of the world's largest online retailers.
365 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| KRTXKaruna Therapeutics | US$240.22 | 2.7% | 139.5% | US$9.0b | US$274.00 | PS796.6x | E51.0% | n/a | ||
| RGENRepligen | US$161.43 | -1.7% | 14.5% | US$9.0b | US$202.33 | PE53.6x | E2.8% | n/a | ||
| TEVATeva Pharmaceutical Industries | US$7.46 | 0.9% | -2.2% | US$8.4b | US$9.80 | PB1.1x | E52.2% | 0% | ||
| JAZZJazz Pharmaceuticals | US$126.55 | -0.8% | -11.2% | US$8.1b | US$199.29 | PS2.2x | E30.7% | n/a | ||
| STVNStevanato Group | US$30.59 | 5.3% | 102.0% | US$8.1b | US$31.85 | PE52.2x | E13.3% | 0.2% | ||
| CTLTCatalent | US$42.09 | 7.9% | -58.2% | US$7.6b | US$50.77 | PE361.3x | E63.0% | n/a | ||
| ROIVRoivant Sciences | US$9.71 | 1.4% | 154.2% | US$7.4b | US$13.61 | PS170.8x | E41.4% | n/a | ||
| TXG10x Genomics | US$57.62 | 6.1% | 55.3% | US$6.7b | US$58.50 | PS12.5x | E60.3% | n/a | ||
| MEDPMedpace Holdings | US$218.30 | -1.5% | 65.0% | US$6.7b | US$224.75 | PE25.9x | E8.0% | n/a | ||
| ITCIIntra-Cellular Therapies | US$64.40 | -1.3% | 20.5% | US$6.2b | US$76.50 | PS19.9x | E64.6% | n/a | ||
| EXELExelixis | US$18.78 | -2.9% | 6.9% | US$6.1b | US$25.31 | PE39.8x | E27.5% | n/a | ||
| IONSIonis Pharmaceuticals | US$40.82 | -2.0% | 21.0% | US$5.8b | US$50.01 | PS10.1x | E33.5% | n/a | ||
| NTRANatera | US$50.47 | 3.4% | 53.1% | US$5.8b | US$74.53 | PS6.6x | E50.0% | n/a | ||
| CERECerevel Therapeutics Holdings | US$34.17 | 1.5% | 49.2% | US$5.4b | US$36.33 | PB12.4x | E-4.2% | n/a | ||
| HIKHikma Pharmaceuticals | UK£19.25 | 4.7% | 29.6% | UK£4.2b | UK£20.82 | PE28.7x | E14.6% | 2.3% | ||
| ALKSAlkermes | US$31.76 | 0.7% | 17.6% | US$5.3b | US$36.22 | PS4.7x | E59.5% | n/a | ||
| ISEEIVERIC bio | US$38.14 | -0.2% | 283.7% | US$5.3b | US$40.00 | PB11x | E62.1% | n/a | ||
| DPHDechra Pharmaceuticals | UK£36.40 | 0.3% | 17.0% | UK£4.1b | UK£39.53 | PE103.4x | E24.2% | 1.2% | ||
| OGNOrganon | US$20.29 | 1.4% | -38.2% | US$5.2b | US$29.67 | PE6.9x | E11.7% | 5.5% | ||
| ASNDAscendis Pharma | US$90.37 | -2.0% | 15.0% | US$5.1b | US$135.77 | PS60.2x | E52.7% | n/a | ||
| CRSPCRISPR Therapeutics | US$58.96 | -5.8% | -8.8% | US$4.9b | US$84.76 | PS49x | E46.6% | n/a | ||
| PCVXVaxcyte | US$52.40 | 2.8% | 179.6% | US$4.9b | US$66.29 | PB5.2x | E-3.9% | n/a | ||
| ELANElanco Animal Health | US$9.85 | 5.3% | -51.4% | US$4.9b | US$13.19 | PS1.1x | E35.9% | n/a | ||
| MDGLMadrigal Pharmaceuticals | US$256.71 | -4.6% | 294.6% | US$4.7b | US$331.17 | PB31.3x | E66.6% | n/a |